What is the ticker symbol for Carmell Therapeutics?

Carmell Therapeutics trades under the ticker CTCXW on NASDAQ.

What sector does Carmell Therapeutics operate in?

Carmell Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CTCXW in a portfolio?

PortView shows CTCXW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Carmell Therapeutics (CTCXW) Stock Analysis

NASDAQHealthcareBiotechnology

$0.03-45.40%

1-year price historyRange $0.02 – $0.50

52-week range$0.03

$0.02$0.06

What Carmell Therapeutics does

Carmell Therapeutics Corporation concentrates its efforts on developing sophisticated plasma-derived bioactive materials (PBMs) engineered to promote tissue regeneration and healing. These innovative biomaterials are designed to assist the body's repair mechanisms following trauma, disease, or age-related degeneration. Its flagship experimental product, CT-101, acts as a bone healing accelerator with a wide array of intended uses, including the rapid mending of fractured tibias, facilitating foot and ankle joint fusion, aiding spinal fusion surgeries, serving as an alternative for dental bone grafts, and filling bone voids. Additionally, the company is advancing a separate tissue repair compound aimed at treating androgenetic alopecia (pattern baldness) and expediting the closure of chronic wounds. This enterprise was founded in 2008 and operates from its headquarters in Pittsburgh, Pennsylvania.

Key metrics

Market cap

$558,174

P/E (TTM)

0.00

Beta

0.14

Dividend yield

0.00%

Revenue / share

$0.68

50-day avg

$0.04

200-day avg

$0.07

52-week high

$0.06

52-week low

$0.02

CEO

Rajiv Sarman Shukla

ETFs linked to CTCXW

Broad-market and Healthcare sector ETFs an investor holding Carmell Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CTCXW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CTCXW in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Carmell Therapeutics?: Carmell Therapeutics trades under the ticker CTCXW on NASDAQ.
Which exchange is CTCXW listed on?: CTCXW is listed on NASDAQ.
What sector does Carmell Therapeutics operate in?: Carmell Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CTCXW in a portfolio?: PortView shows CTCXW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.